Device-Like System Proposed For Low-Risk Human Cell Therapies, Tissue-Based Products At US FDA

The FDA wants to revamp its current regulatory framework for human cell and tissue-based therapies. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Pathways & Standards